These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 325832)

  • 1. Influence of azathioprine and prednisone in vivo treatment on lymphocyte-dependent antibody-mediated cytotoxicity (LDAC) in 57 human renal allograft recipients.
    Descamps B; Gagnon R; van Der Gaag R; Meyer O; Crosnier J
    Transplant Proc; 1977 Mar; 9(1):981-4. PubMed ID: 325832
    [No Abstract]   [Full Text] [Related]  

  • 2. Donor-specific cell-mediated cytotoxicity in renal allograft recipients.
    Dickmeiss E
    Acta Pathol Microbiol Scand C; 1979 Dec; 87(6):371-76. PubMed ID: 397716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azathioprine suppression of natural killer activity and antibody-dependent cellular cytotoxicity in renal transplant recipients.
    Prince HE; Ettenger RB; Dorey FJ; Fine RN; Fahey JL
    Transplant Proc; 1984 Dec; 16(6):1475-7. PubMed ID: 6390849
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship of mixed lymphocyte culture response, HL-A histocompatibility antigens, and renal transplantation.
    Thompson JS; Flink RJ; Caldwell JL; Severson CD; Bonney WW
    Transplant Proc; 1973 Dec; 5(4):1763-9. PubMed ID: 4130081
    [No Abstract]   [Full Text] [Related]  

  • 5. Planned preimmunization of renal allograft recipients.
    Newton WT; Anderson CB
    Surgery; 1973 Sep; 74(3):430-6. PubMed ID: 4269174
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of whole blood for antibody-dependent cell-mediated cytotoxicity in kidney patients.
    Dupont E
    Proc Eur Dial Transplant Assoc; 1977; 14():321-7. PubMed ID: 341133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical aspects of allograft rejection.
    Williams GM
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):71-7. PubMed ID: 4612907
    [No Abstract]   [Full Text] [Related]  

  • 8. Contrasting results of immunological monitoring in cyclosporine- and azathioprine-treated renal allograft recipients.
    Waltzer WC; Arnold AN; Anaise D; Rapaport FT
    Transplant Proc; 1986 Aug; 18(4):970-3. PubMed ID: 3526668
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibody-dependent cell-mediated cytotoxicity in prospective kidney transplant recipients.
    Lightbody JJ; Rosenberg JC
    J Immunol; 1974 Mar; 112(3):890-6. PubMed ID: 4590706
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell-mediated cytotoxicity to muscle in polymyositis. Effect of immunosuppression.
    Dawkins RL; Mastaglia FL
    N Engl J Med; 1973 Mar; 288(9):434-8. PubMed ID: 4734262
    [No Abstract]   [Full Text] [Related]  

  • 11. New perspectives on pathogenesis and treatment of rejection in kidney transplantation.
    Merrill JP
    Kidney Int Suppl; 1975 Feb; (3):318-22. PubMed ID: 1099311
    [No Abstract]   [Full Text] [Related]  

  • 12. Analyses of histocompatibility in cadaver renal transplantation.
    Morris PJ
    Transplant Proc; 1971 Jun; 3(2):1030-5. PubMed ID: 4944045
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of rabbit ATG in cadaver kidney transplantation: an updated report with consideration of presensitized recipients.
    Davis RC; Nabseth DC; Olsson CA; Idelson BA; Schmitt GW; Cho SI; Mannick JA
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):67-70. PubMed ID: 4612906
    [No Abstract]   [Full Text] [Related]  

  • 14. The influence of therapy with azathioprine and prednisone on the immune system of kidney transplant recipients.
    ten Berge RJ; Schellekens PT; Surachno S; The TH; ten Veen JH; Wilmink JM
    Clin Immunol Immunopathol; 1981 Oct; 21(1):20-32. PubMed ID: 7023763
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal transplantation between histocompatible donor-recipient pairs.
    Seigler HF; Stickel DL; Gunnells JC; McCoy R; Ward FE; Anderson EE; Amos DB
    Transplant Proc; 1972 Dec; 4(4):439-46. PubMed ID: 4264867
    [No Abstract]   [Full Text] [Related]  

  • 16. Homograft survival and serum-blocking factors.
    Quadracci LJ; Pierce GE; Striker GE; Tremann JA; Marchioro TL
    Transplant Proc; 1973 Mar; 5(1):649-53. PubMed ID: 4572123
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of histocompatibility on graft and patient survival in primary cadaver kidney transplantation.
    Storm B; Lindholm A
    Proc Eur Dial Transplant Assoc; 1972; 9():466-74. PubMed ID: 4589765
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification and function of a major OKT3, OKT8, Leu-7, positive lymphocyte subpopulation in renal transplant recipients treated with total lymphoid irradiation.
    Waer M; Vanrenterghem Y; Van der Schueren E; Michielsen P; Vandeputte M
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1570-1. PubMed ID: 3079027
    [No Abstract]   [Full Text] [Related]  

  • 19. Triple immunosuppressive therapy in immunologic high-risk renal allograft recipients.
    Cole E; Robinson C; Bear R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2026-7. PubMed ID: 2652662
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperacute and acute fulminating rejection of human renal allografts.
    Williams GM; Sterioff S; Bias W
    Transplant Proc; 1972 Dec; 4(4):665-7. PubMed ID: 4566816
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.